Cargando…

Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel

In June 2011 the Canadian National Advisory Committee on Blood and Blood Products sponsored an international consensus conference on transfusion and trauma. A panel of 10 experts and two external advisors reviewed the current medical literature and information presented at the conference by invited...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzik, Walter H, Blajchman, Morris A, Fergusson, Dean, Hameed, Morad, Henry, Blair, Kirkpatrick, Andrew W, Korogyi, Teresa, Logsetty, Sarvesh, Skeate, Robert C, Stanworth, Simon, MacAdams, Charles, Muirhead, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388668/
https://www.ncbi.nlm.nih.gov/pubmed/22188866
http://dx.doi.org/10.1186/cc10498
_version_ 1782237222856032256
author Dzik, Walter H
Blajchman, Morris A
Fergusson, Dean
Hameed, Morad
Henry, Blair
Kirkpatrick, Andrew W
Korogyi, Teresa
Logsetty, Sarvesh
Skeate, Robert C
Stanworth, Simon
MacAdams, Charles
Muirhead, Brian
author_facet Dzik, Walter H
Blajchman, Morris A
Fergusson, Dean
Hameed, Morad
Henry, Blair
Kirkpatrick, Andrew W
Korogyi, Teresa
Logsetty, Sarvesh
Skeate, Robert C
Stanworth, Simon
MacAdams, Charles
Muirhead, Brian
author_sort Dzik, Walter H
collection PubMed
description In June 2011 the Canadian National Advisory Committee on Blood and Blood Products sponsored an international consensus conference on transfusion and trauma. A panel of 10 experts and two external advisors reviewed the current medical literature and information presented at the conference by invited international speakers and attendees. The Consensus Panel addressed six specific questions on the topic of blood transfusion in trauma. The questions focused on: ratio-based blood resuscitation in trauma patients; the impact of survivorship bias in current research conclusions; the value of nonplasma coagulation products; the role of protocols for delivery of urgent transfusion; the merits of traditional laboratory monitoring compared with measures of clot viscoelasticity; and opportunities for future research. Key findings include a lack of evidence to support the use of 1:1:1 blood component ratios as the standard of care, the importance of early use of tranexamic acid, the expected value of an organized response plan, and the recommendation for an integrated approach that includes antifibrinolytics, rapid release of red blood cells, and a foundation ratio of blood components adjusted by results from either traditional coagulation tests or clot viscoelasticity or both. The present report is intended to provide guidance to practitioners, hospitals, and policy-makers.
format Online
Article
Text
id pubmed-3388668
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33886682012-12-08 Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel Dzik, Walter H Blajchman, Morris A Fergusson, Dean Hameed, Morad Henry, Blair Kirkpatrick, Andrew W Korogyi, Teresa Logsetty, Sarvesh Skeate, Robert C Stanworth, Simon MacAdams, Charles Muirhead, Brian Crit Care Review In June 2011 the Canadian National Advisory Committee on Blood and Blood Products sponsored an international consensus conference on transfusion and trauma. A panel of 10 experts and two external advisors reviewed the current medical literature and information presented at the conference by invited international speakers and attendees. The Consensus Panel addressed six specific questions on the topic of blood transfusion in trauma. The questions focused on: ratio-based blood resuscitation in trauma patients; the impact of survivorship bias in current research conclusions; the value of nonplasma coagulation products; the role of protocols for delivery of urgent transfusion; the merits of traditional laboratory monitoring compared with measures of clot viscoelasticity; and opportunities for future research. Key findings include a lack of evidence to support the use of 1:1:1 blood component ratios as the standard of care, the importance of early use of tranexamic acid, the expected value of an organized response plan, and the recommendation for an integrated approach that includes antifibrinolytics, rapid release of red blood cells, and a foundation ratio of blood components adjusted by results from either traditional coagulation tests or clot viscoelasticity or both. The present report is intended to provide guidance to practitioners, hospitals, and policy-makers. BioMed Central 2011 2011-12-08 /pmc/articles/PMC3388668/ /pubmed/22188866 http://dx.doi.org/10.1186/cc10498 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Review
Dzik, Walter H
Blajchman, Morris A
Fergusson, Dean
Hameed, Morad
Henry, Blair
Kirkpatrick, Andrew W
Korogyi, Teresa
Logsetty, Sarvesh
Skeate, Robert C
Stanworth, Simon
MacAdams, Charles
Muirhead, Brian
Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
title Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
title_full Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
title_fullStr Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
title_full_unstemmed Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
title_short Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
title_sort clinical review: canadian national advisory committee on blood and blood products - massive transfusion consensus conference 2011: report of the panel
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388668/
https://www.ncbi.nlm.nih.gov/pubmed/22188866
http://dx.doi.org/10.1186/cc10498
work_keys_str_mv AT dzikwalterh clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT blajchmanmorrisa clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT fergussondean clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT hameedmorad clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT henryblair clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT kirkpatrickandreww clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT korogyiteresa clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT logsettysarvesh clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT skeaterobertc clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT stanworthsimon clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT macadamscharles clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel
AT muirheadbrian clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel